- サングラス
o フォトクロミックレンズ
o 偏光レンズ
o その他
- 人工コンタクトレンズ
- 手術
- 薬物乱用リハビリ
- 点眼薬
o アトロピン
o マイドリレート
o ホマトロピン
o フェニレフリン
o その他
- その他
販売チャネル別
- 販売チャネル
o 病院薬局
o 小売薬局
o オンライン薬局
- エンドユーザー
o 病院
o 眼科クリニック
o リハビリセンター
o 外来手術センター
o 学術研究機関
o その他
地域別
- 北米
o アメリカ
o カナダ
o メキシコ
- ヨーロッパ
o ドイツ
イギリス
o フランス
o スペイン
o イタリア
o その他のヨーロッパ
- 南米
o ブラジル
o アルゼンチン
o その他の南米
- アジア太平洋
o 中国
o インド
o 日本
o オーストラリア
o その他のアジア太平洋
- 中東・アフリカ
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Treatment Type
3.2. Snippet by Sales Channel
3.3. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Adoption of Ophthalmic Solutions
4.1.2. Restraints
4.1.2.1. Complications Associated with the Surgery
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Pipeline Analysis
5.6. Unmet Needs
5.7. Patent Analysis
5.8. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Treatment Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
7.1.2. Market Attractiveness Index, By Treatment Type
7.2. Sunglasses*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.2.3. Photochromic Lenses
7.2.4. Polarized Lenses
7.2.5. Others
7.3. Prosthetic Contact Lenses
7.4. Surgery
7.5. Substance Abuse Rehabilitation
7.6. Eye Drops
7.6.1. Atropine
7.6.2. Mydrilate
7.6.3. Homatropine
7.6.4. Phenylephrine
7.6.5. Others
7.7. Others
8. By Sales Channel
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
8.1.2. Market Attractiveness Index, By Sales Channel
8.2. Distribution Channel*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.2.3. Hospital Pharmacies
8.2.4. Retail Pharmacies
8.2.5. Online Pharmacies
8.3. End-User
8.3.1. Hospitals
8.3.2. Ophthalmic Clinics
8.3.3. Rehabilitation Centers
8.3.4. Ambulatory Surgical Centers
8.3.5. Academic and Research Institutes
8.3.6. Others
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.5.1. U.S.
9.2.5.2. Canada
9.2.5.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.5.1. Germany
9.3.5.2. UK
9.3.5.3. France
9.3.5.4. Italy
9.3.5.5. Spain
9.3.5.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.5.1. Brazil
9.4.5.2. Argentina
9.4.5.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.5.1. China
9.5.5.2. India
9.5.5.3. Japan
9.5.5.4. Australia
9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Omeros Corporation*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. Théa Laboratories
11.3. Ocuphire Pharma, Inc.
11.4. Alcon Inc.
11.5. Hoya Vision
11.6. Maui Jim USA, Inc.
11.7. Safilo Group S.p.A.
11.8. Global Calcium Pvt Ltd
11.9. VISION EASE
11.10. ZEISS Group
12. Appendix
12.1. About Us and Services
12.2. Contact Us
